Biotech consulting, scientific websites and content, expert calls and career coaching

Auralis Biotech is a European biotech consultancy founded in Italy in 2025 by Dr. Giuseppina Sannino. We help startups, companies and investors understand and commercialize life science innovation, from diagnostics, agrifood and environment to drug discovery and every field of biology. Our services include business strategy, go-to-market and EU market entry, scientific content and websites, and expert calls. Working with clients in Europe, the US, the Middle East and Asia.

Request a discovery call
  • Biotech consulting

    Business strategy, positioning, go-to-market and EU market entry for biotech and life science companies.

    • Fractional business development
    • Scientific marketing and partner introductions
    • Representation of non-EU companies in Europe
    • Fundraising and investor identification
    • Exit preparation and acquirer identification
    Learn more 
  • Scientific websites and content

    Scientific content and websites for biotech and life science companies.

    • Product pages and application notes
    • SEO and GEO content for search engines and AI answers
    • Marketing materials and white papers
    • Biotech website design and structure
    Learn more 
  • Biotech training and career coaching

    Biotech business development training and career coaching for scientists, small companies and corporates.

    • Customized biotech BD trainings for small companies and corporates
    • On-demand course for scientists moving into biotech sales and business development (pre-registration open)
    • 1:1 coaching for the move from academia to industry, as a single call or a package of 3 to 5 meetings
    Learn more 
  • Expert calls

    We help investors and companies understand markets, technologies and competitors in immunodiagnostics and molecular diagnostics.

    • Market landscape
    • OEM and CDMO models
    • Supplier qualification
    • Competitors and new trends
    Learn more 
1 of 4

How we work

From the first call to ongoing support, with a dedicated point of contact. If needed, we bring in the specialist partners the project needs, from laboratories and CROs to legal and financial advisors.

  1. Discovery callYou share your science, goals and challenges.
  2. AssessmentWe map your needs across strategy, marketing, partnerships and commercial positioning.
  3. Custom planA tailored roadmap with milestones and deliverables.
  4. ExecutionWe carry out the plan with you: outreach to customers, partners and investors, representation in Europe and scientific content.
  5. Ongoing supportContinuous advice and partner introductions as your project evolves.
Request a discovery call

Assess your market readiness

Not sure which stage applies to you? Our free market readiness audit helps you understand your commercial position, identify gaps, and chart a clear path forward.

  • TECAN

    Client: Global supplier of laboratory automation and liquid handling platforms.

    Challenge: Combine three kinds of expertise on one project: scientific depth, commercial judgement that shapes how the content sells, and page structure built for SEO and for AEO/GEO alike.

    Our work: Scientific content partner for the laboratory automation portfolio, covering new web, product and applications content.

    Result: Pages built so that an answer engine can quote them as readily as a search engine ranks them.

  • Trustech Diagnostics logo

    Trustech Diagnostics

    Client: Italian deep-tech company developing EliChip, a portable immunodiagnostic platform.

    Challenge: take the platform to market and find the right investors and partners.

    Our work: fractional business development, from go-to-market direction and partner identification to the scientific content and the EliChip landing page.

    Result: first early adopter program contract signed, an EU grant application in evaluation and 3 potential partnerships in discussion.

    View the EliChip landing page 
  • Pauling.AI logo

    Pauling.AI

    Client: US company with an autonomous AI platform for computational drug discovery.

    Challenge: find customers and partners outside the United States.

    Our work: ideal customer profile, qualified introductions through our network and identification of channel partners.

    Result: 2 channel partners within 3 months of the agreement, including a New Approach Methodologies hub and a partner based in the Middle East.

    Discover Pauling.AI 
  • Digital marketing agency case scenario illustration

    Digital Marketing Agency

    Client: full-service digital agency working in various industries, including biopharma and biotech.

    Challenge: keep biotech client content scientifically accurate and relevant to the right audience.

    Our work: Auralis acts as the embedded scientific layer, covering website copywriting and scientifically grounded SEO and GEO, among other work.

    Result: scientific accuracy and audience relevance built into the agency's biotech projects.

  • M&A boutique advisory collaboration illustration

    M&A Boutique Advisory Collaboration

    Client: Italian M&A boutique based in Turin, working in various industries.

    Challenge: support transactions involving biotech and medical technology companies with sector expertise.

    Our work: commercial strategy, go-to-market direction and strategic partner identification. The boutique's team handles financial structuring and deal execution.

    Result: biotech and medtech transactions supported by commercial and strategic input from Auralis.

1 of 5

Why Auralis Biotech

Most projects need several skills at once: the science, the marketing and the business development. At Auralis they come together in one team, led by Dr. Giuseppina Sannino, a molecular biologist with a PhD in Cancer Biology and more than ten years of international experience in diagnostics, biopharma and molecular tools commercialization.

  • Science, marketing and business development together. We understand your data, turn it into a message that technical buyers trust and take it to customers, partners and investors.
  • AI tools in our daily work. We use AI tools for research, content and outreach, combined with scientific and commercial judgement.
  • Flexible, customized plans. No fixed packages: scope and timing are built around your stage and your goals.
  • Part of your team. We work as an extension of your own team, with a dedicated point of contact.
About the founder
  • Global R&D Director

    "Giuseppina demonstrates an excellent combination of scientific expertise with a drive for business growth. She is very good at translating the needs of customers from various application areas of molecular biology into business objectives and actions."

  • Managing Director

    "What sets Giuseppina apart is her ability to seamlessly combine business acumen with a strong scientific understanding, particularly in the field of molecular diagnostics."

  • Communications and Content Strategist

    "Giusy is a unique blend of curious scientist and astute business developer. [...] Our marketing materials and customer outreach were always more targeted when Giusy was involved."

  • Freelance Author and Consultant

    "Giusy is results-driven, maintaining close contact with customers and consistently delivering on her promises."

1 of 4
  • What Is Fractional Business Development in Biotech?

    What fractional business development is, who it suits and how it works for biotech and life science companies.

    Read the guide 
  • How Investors Use Expert Calls in Biotech Due Diligence

    How investors use expert calls to test markets, technologies and competitors during biotech due diligence.

    Read the guide 
  • SEO and GEO for Biotech Websites: Improving Visibility in Search and AI Answers

    How to structure biotech website content so that search engines and AI answers can find and cite it.

    Read the guide 
1 of 3

Latest from Auralis

New programme

The Scientist's Bridge: Essentials

On-demand online course for scientists moving into biotech sales and business development. Launching on 3 November 2026 in English, with subtitles in English, Italian and German. Pre-register to get 20% off the launch price.

Register interest
Dr. Giuseppina Sannino, founder of Auralis Biotech

In the press

CEO Weekly interview

CEO Weekly features our founder, Dr. Giuseppina Sannino, on building the bridge between science and the market. July 2026.

Read the interview
Article by Auralis Biotech in Pharma Focus Asia, Issue 62, 2026

In the press

Pharma Focus Asia, Issue 62

How point-of-need biotechnologies are redefining microbiological quality control in biopharma manufacturing. 2026.

Read the article

Partner technology

EliChip

Microfluidic immunodiagnostic platform developed by Trustech Diagnostics. Quantitative, ELISA-grade results outside the central laboratory: 20 µL of sample, digital result in under an hour, TRL-7. Auralis Biotech is the commercial partner for the EliChip Early Adopter Program. For research and development use.

Discover EliChip

Frequently asked questions

Where is Auralis Biotech based?

Auralis Biotech is headquartered in Civitanova Marche, Italy. We work with biotech, diagnostics and life science companies and investors in Europe, the US, the Middle East and Asia.

Who is behind Auralis Biotech?

Auralis Biotech is led by Giuseppina Sannino, PhD, CEO and Founder. She holds a PhD in Cancer Biology from the University of Tübingen and has over 10 years of international experience in diagnostics, biopharma and molecular tools commercialization across Europe, Africa, North America and China.

Can you help a non-EU company enter the European market?

Yes. We act as a local commercial partner in Europe: EU market entry strategy, distributor scouting and partner introductions for companies from the US, Asia and other regions.

Do you distribute technologies in Europe?

Yes, in two ways. For selected manufacturers we act as direct distributor in Europe and manage procurement, logistics and customer relationships, as for the Maverick16 qPCR system. For other platforms we work as fractional commercial partner: we find the right distributors, research institutions and industry buyers and build the commercial setup for European market entry, without taking on distribution. See our partner technologies.

Can you help European companies enter the US market?

Yes, for human-relevant preclinical technologies. Through our partnership with NAMina Bio, European developers of organ-on-chip systems, 3D and tumoroid models and AI tools for assay confidence can explore entry into the US market and collaboration on specific preclinical programmes. Read more about NAMina Bio.

Which fields do you cover?

Anything related to biology: diagnostics (including immunodiagnostics and molecular diagnostics), agrifood, environment, drug discovery and the wider life sciences.

How do expert calls work?

Investors and companies request a one-to-one call with Dr. Giuseppina Sannino, a molecular biologist with a PhD in Cancer Biology, to understand a technology, market or competitor in immunodiagnostics or molecular diagnostics. Calls typically last 60 to 90 minutes and can be booked directly with us or through dedicated expert network platforms. Typical topics include market landscape, OEM and CDMO models, supplier qualification, competitors and new trends.

What does Auralis Biotech do?

Auralis Biotech is a European biotech consultancy founded in Italy in 2025 by Giuseppina Sannino, PhD. It helps startups, companies and investors with strategy and go-to-market, EU market entry, scientific websites and content, and expert calls. We also coach scientists who want to move into biotech business development.

How does a project with Auralis Biotech start?

With a discovery call, where you share your science, goals and challenges. We then assess your needs, agree a custom plan with milestones and deliverables, carry it out with you and keep supporting the project as it evolves.

What results have clients achieved with Auralis Biotech?

For Trustech Diagnostics and its EliChip platform, the first early adopter program contract was signed, an EU grant application is in evaluation and 3 potential partnerships are in discussion. For a US AI drug discovery platform, the result was 2 channel partners within 3 months of the agreement, including a New Approach Methodologies hub and a partner in the Middle East.

Do you work with partners?

Yes. Bringing a technology to market needs skills that rarely sit in one organization. Auralis Biotech coordinates a network of specialist partners, including technology and industrial partners, laboratories and CROs, investors and funding bodies, and legal and financial advisors, and brings in the ones each project needs, with one point of contact.

Who do you work with?

Startups, spin-offs, SMEs and larger biotech, diagnostics and life science companies at any stage, from Build to Exit, non-EU companies entering the European market, and investors and consultancies that book expert calls.

Can you create and build scientific websites?

Yes. We design and create websites, product pages, white papers and articles for biotech and life science companies. Every project is led by a scientist with commercial experience, so the science stays accurate and the message stays commercial.

Do you offer career coaching for scientists?

Yes. The on-demand course The Scientist's Bridge: Essentials is for scientists moving into biotech business development and sales. It launches on 3 November 2026 in English with subtitles in English, Italian and German. Pre-register to get 20% off the launch price. We also offer 1:1 coaching, as a single call or a package of 3 to 5 meetings, and customized trainings for company teams.